Skip to main content
Figure 2 | Allergy, Asthma & Clinical Immunology

Figure 2

From: Multiple-allergen oral immunotherapy improves quality of life in caregivers of food-allergic pediatric subjects

Figure 2

Percentages of participants with deterioration, no change, or improvement in HRQL scores. Percentages of participants whose HRQL scores deteriorated (change > 0.5), remained unchanged (change between -0.5 and 0.5), or improved (change < -0.5) in the control group, mOIT group, and rush mOIT group at (A) 6-month follow-up and (B) 18-month follow-up.

Back to article page